This study analyzed the clinical significance of a canonical CAF marker, FAP, in pretreatment tumor specimens to determine its association with T cell infiltration and immunotherapy outcomes in advanced NSCLC. This evidence concerns the gene FAP and non-small cell lung carcinoma.